---
title: "MBRX.US (MBRX.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/MBRX.US/news.md"
symbol: "MBRX.US"
name: "MBRX.US"
parent: "https://longbridge.com/en/quote/MBRX.US.md"
datetime: "2026-05-20T01:40:41.622Z"
locales:
  - [en](https://longbridge.com/en/quote/MBRX.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/MBRX.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/MBRX.US/news.md)
---

# MBRX.US (MBRX.US) — Related News

### [Moleculin Reports First Quarter 2026 Financial Results and Provides Clinical Update on Pivotal MIRACLE Trial](https://longbridge.com/en/news/286568391.md)
*2026-05-15T12:32:29.000Z*
> Preliminary data from the MIRACLE Trial reveals an impressive 40% overall complete remission rate in a challenging group

### [Moleculin Biotech | 8-K: FY2026 Q1 Revenue: USD 0](https://longbridge.com/en/news/286566040.md)
*2026-05-15T12:32:26.000Z*
### [Moleculin Biotech | 10-Q: FY2026 Q1 Revenue: USD 0](https://longbridge.com/en/news/286459134.md)
*2026-05-14T20:03:27.000Z*
### [Buy Rating Reiterated on Moleculin Biotech as MIRACLE Trial Progress Supports Unchanged $10 Price Target](https://longbridge.com/en/news/286457097.md)
*2026-05-14T19:25:16.000Z*
> Analyst Jason McCarthy of Maxim Group has reiterated a Buy rating on Moleculin Biotech, maintaining a price target of $1

### [U.S. stock market movement update: Cisco surged 20.06%, Moleculin Biotech rose 10.75%, Kingsoft Cloud fell 9.04%](https://longbridge.com/en/news/286380106.md)
*2026-05-14T08:00:16.000Z*
> In the past hour, the overall market in the US stock market has shown a clear divergence, with technology and biotechnol

### [U.S. stock market movement update: Cisco surged nearly 20%, Moleculin Biotech rose 15.89%, Jianzhi Edu Tech fell 8.83%](https://longbridge.com/en/news/286372521.md)
*2026-05-14T07:00:16.000Z*
> In the past hour, the overall market in the U.S. stock market has shown a clear divergence, with technology and biotechn

### [U.S. stock market movement update: Cisco surged 20.27%, Moleculin Biotech rose 19.63%, Jianzhi Edu Tech fell 8.83%](https://longbridge.com/en/news/286365108.md)
*2026-05-14T06:00:16.000Z*
> In the past hour, the overall market in the US stock market has shown a clear divergence, with technology and biotechnol

### [Moleculin Nears First Unblinding in Pivotal MIRACLE Trial](https://longbridge.com/en/news/286263542.md)
*2026-05-13T12:33:26.000Z*
> Moleculin Biotech (MBRX) is nearing the first unblinding of data from its pivotal Phase 2B/3 MIRACLE trial for Annamycin